IGF2BP2 and hepatocellular carcinoma: According to the growth curves derived from the CCK‐8 assay, IGF2BP2 overexpression promoted the proliferation of MDA‐MB‐231 and HCC‐1806 cell lines, while knockdown of IGF2BP2 could slow down the growth rate of these two cell lines (Figure 3C and Figure 4C).